Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Pfizer's Q3: Stagnation Continues
09:26am, Tuesday, 04'th Nov 2025
Pfizer reported another quarter of stagnation, with Q3 2025 revenue and EPS both declining year-over-year despite beating consensus estimates. PFE's revenue mix remains weak, with Primary Care sales d
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up
09:20am, Tuesday, 04'th Nov 2025
Novo Nordisk and Pfizer have revised their bids for Metsera , the obesity drug developer said on Tuesday.
Metsera Receives Amended Proposal from Novo Nordisk; Metsera Declares Novo Nordisk Amended Proposal "Superior"
09:09am, Tuesday, 04'th Nov 2025
Novo Nordisk Amended Proposal Values Metsera at up to $ 86.20 per Share, a Total of Approximately $ 10.0 Billion Superior to Revised Pfizer Proposal that Valued Metsera at up to $ 70.00 per Share, a T
Pfizer (PFE) Surpasses Q3 Earnings and Revenue Estimates
09:01am, Tuesday, 04'th Nov 2025
Pfizer (PFE) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $1.06 per share a year ago.
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (November 2025)
08:00am, Tuesday, 04'th Nov 2025
Shares of Pfizer ( NYSE: PFE ) lost 9.90% over the past month after gaining 10.02% the month prior.
Pfizer's $4.9 Billion Gamble: Inside Its Legal War to Reclaim the Obesity Market
07:35am, Tuesday, 04'th Nov 2025
Pfizer (PFE) raised its 2025 profit outlook again, signaling that cost discipline may be starting to pay off after a bruising few years. The company now expects
Pfizer Inc (PFE) Q3 2025 Earnings: EPS of $0.62 Beats Estimates, Revenue Hits $16.7 Billion
07:31am, Tuesday, 04'th Nov 2025
Revenue: $16.7 billion for Q3 2025, slightly surpassing the estimated $16.59 billion, despite a 6% year-over-year decline.Earnings Per Share (EPS): Reported di
Pfizer Profit Falls Amid Lower Covid-19 Drug Demand
07:04am, Tuesday, 04'th Nov 2025
Pfizer reported lower third-quarter profit as demand for its Covid-19 vaccine and antiviral drug continue to decline.
Pfizer tops estimates, raises profit guidance even as sales fall
06:56am, Tuesday, 04'th Nov 2025
Pfizer reported third-quarter earnings and revenue that topped estimates and hiked its full-year profit outlook as it cuts costs, even as sales for the period fell. The results come weeks after Pfizer
Pfizer raises 2025 profit forecast for second time in a row
06:49am, Tuesday, 04'th Nov 2025
Pfizer lifted its full-year profit forecast for the second time in a row on Tuesday, buoyed by strong demand for its blockbuster heart treatment and blood thinner.
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance
06:45am, Tuesday, 04'th Nov 2025
NEW YORK--(BUSINESS WIRE)--Pfizer Q3-25 Earnings Release.
Best Medical Stocks To Watch Today – November 2nd
03:05am, Tuesday, 04'th Nov 2025
Eli Lilly and Company, Pfizer, UnitedHealth Group, AbbVie, and Johnson and Johnson are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. "Medical stocks" are share
Top Pharmaceutical Stocks To Follow Now – November 2nd
03:05am, Tuesday, 04'th Nov 2025
Eli Lilly and Company, Pfizer, and AbbVie are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded compani
Pfizer Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
02:49am, Tuesday, 04'th Nov 2025
Pfizer Inc. (NYSE:PFE) will release earnings results for the third quarter before the opening bell on Tuesday, Nov. 4.
Novo Nordisk CEO faces baptism of fire amid board shakeup, Pfizer fight
01:03am, Tuesday, 04'th Nov 2025
Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues a bidding war with U.S. rival Pfizer.
